88808578 - AVIDITY

Information

  • Trademark
  • 88808578
  • Serial Number
    88808578
  • Registration Number
    6147100
  • Filing Date
    February 24, 2020
    5 years ago
  • Registration Date
    September 08, 2020
    4 years ago
  • Transaction Date
    February 18, 2022
    3 years ago
  • Status Date
    September 08, 2020
    4 years ago
  • Published for Opposition Date
    June 23, 2020
    4 years ago
  • Location Date
    September 08, 2020
    4 years ago
  • First Use Anywhere Date
    January 01, 2019
    6 years ago
  • First Use In Commerce Date
    January 01, 2019
    6 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    KEELEY, ALISON REBECCA
  • Attorney Docket Number
    45532-TM1001
    Attorney Name
    Aaron D. Hendelman
    Law Office Assigned Location Code
    M40
  • Owners
Mark Drawing Code
4000
Mark Identification
AVIDITY
Case File Statements
  • GS0421: Research and development in the pharmaceutical and biotechnology fields, namely, research and development for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; research and development for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical and scientific research services for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; development of pharmaceutical preparations and medicines, namely, the development of oligonucleotide-based therapeutics
Case File Event Statements
  • 2/18/2022 - 3 years ago
    13 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 2/18/2022 - 3 years ago
    12 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/18/2022 - 3 years ago
    11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/18/2022 - 3 years ago
    10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/18/2022 - 3 years ago
    9 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 9/8/2020 - 4 years ago
    8 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/23/2020 - 4 years ago
    7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/23/2020 - 4 years ago
    6 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/3/2020 - 4 years ago
    5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/19/2020 - 4 years ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/12/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/27/2020 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 2/27/2020 - 5 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP